High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function in diabetic hypertensive patients

Cytokine

Volumn 27, Issue 1, 2004, Pages 25-30

  Iacobellis, Gianluca ^a,b   Cipriani, Rosalba ^a   Gabriele, Annarita ^a   Di Mario, Umberto ^a   Morano, Susanna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Growth factors; Hypertension; Left ventricular remodeling; Type 2 diabetes

Indexed keywords

VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOCARDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INJURY; HEART PERFORMANCE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2942744406     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.03.011     Document Type: Article

References (33)

1. Sowers J.R., Epstein M., Frohlich E.D. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 37:2001;1053-1059
2. Namiki A., Brogi E., Kearney M., Kim E.A., Wu T., Couffinhal T., et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 270:1995;31189-31195
3. Kawata H., Yoshida K., Kawamoto A., Kurioka H., Takase E., Sasaki Y., et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res. 88:2001;696-704
4. Ferrara N., Houck K.A., Jakeman L.B., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-42
5. Leung D.W., Cachianes G., Kuang W.J., Goeddl D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309
6. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 18:(104(12 Suppl 1)):2001;I218-I222
7. Henry T.D., Rocha-Singh K., Isner J.M., Kereiakes D.J., Giordano F.J., Simons M., et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J. 142:2001;872-880
8. Jingjing L., Srinivasan B., Bian X., Downey H.F., Roque R.S. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart. Mol Cell Biochem. 214:2000;23-30
9. Felmeden D.C., Spencer C.G., Chung N.A., Belgore F.M., Blann A.D., Beevers D.G., et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol. 15:2003;400-405
10. Lip P.L., Belgore F., Blann A.D., Hope-Ross M.W., Gibson J.M., Lip G.Y. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci. 41:2000;2115-2119
11. Blann A.D., Belgore F.M., McCollum C.N., Silverman S., Lip P.L., Lip G.Y. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond). 102:2002;187-194
12. Hovind P., Tarnow L., Oestergaard P.B., Parving H.H. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl. 75:2000;S56-S61
13. Treins C., Giorgetti-Peraldi S., Murdaca J., Van Obberghen E. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem. 23:2001;43836-43841
14. Zachary I., Mathur A., Yla-Herttuala S., Martin J. Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 20:2000;1512-1520
15. Felmeden D.C., Spencer C.G., Belgore F.M., Blann A.D., Beevers D.G., Lip G.Y. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens. 16:2003;11-20
16. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367
17. Sahn D., DeMaria A., Kisslo J., Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiography measurements. Circulation. 58:1978;1072-1083
18. Deverueux R.B., Alonso D.R., Lutas E.M. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 5:1986;7450-7458
19. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization and comparison to other methods. Hypertension. 9:(Suppl II):1987;II-19-II-20
20. Daniels S.R., Kimball T.R., Morrison J.A., Khoury P., Witt S., Meyer R.A. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: statistical, biological, and clinical significance. Circulation. 92:1995;3249-3254
21. Krumholz H.M., Larson M., Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 25:1995;879-884
22. de Simone G., Devereux R.B., Roman M.J., Savage D.D., Laragh J.H. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 23:1994;1444-1451
23. Hojo Y., Ikeda U., Zhu Y., Okada M., Okada M., Ueno S., et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 35:2000;968-973
24. Soeki T., Tamura Y., Shinohara H., Tanaka H., Bando K., Fukuda N. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology. 93:2000;168-174
25. Sasaki Y., Kawamoto A., Iwano M., Kurioka H., Takase E., Kawata H., et al. Vascular endothelial growth factor mRNA synthesis by peripheral blood mononuclear cells in patients with acute myocardial infarction. Int J Cardiol. 8:2001;151-160
26. VanBruggen W., Bunting S., Ruiz-Lozano P. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci. 98:2001;5780-5785
27. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 49:2000;554-560
28. Jesmin S., Sakuma I., Hattori Y., Fujii S., Kitabatake A. Long-acting calcium channel blocker benipine suppresses expression of angiogenic factors and prevents cardiac remodelling in a type II diabetic rat model. Diabetologia. 45:2002;402-415
29. Ogawa H., Suefuji H., Soejima H., Nishiyama K., Misumi K., Takazoe K., et al. Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology. 93:2000;93-99
30. Cotton J.M., Mathur A., Hong Y., Brown A.S., Martin J.F., Erusalimsky J.D. Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. Eur Heart J. 23:2002;953-959
31. Kyriakides Z.S., Psychari S., Chrysomallis N., Georgiadis M., Sbarouni E., Kremastinos D.T. Type II diabetes does not prevent the recruitment of collateral vessel and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty. Heart. 87:2002;61-66
32. Funatsu H., Yamashita H., Nakanishi Y., Hori S. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophtalmol. 86:2002;311-315
33. Duh E., Aiello L.P. Vascular endothelial growth factor and diabetes. The agonist versus antagonist paradox. Diabetes. 48:1999;1899-1906